Cost-of-illness of COPD in Germany Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003
ILD India registry: results from the new ILD India Registry database Source: International Congress 2016 – Interstitial lung disease registry Year: 2016
Comparison of registries of interstitial lung diseases (ILD) in three European countries Source: Eur Respir J 2001; 18: Suppl. 33, 440s Year: 2001
Treatment and survival diversities in different forms of ILD in Germany - EXCITING registry Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Bronchiectasis in Italy: data from the national registry IRIDE Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Targeted literature review: epidemiology of severe and uncontrolled asthma and associated biomarkers in France, Germany, Italy, Spain and the UK Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Real-world treatment of incident COPD patients in Germany Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Bronchoscopic practice in Germany and other countries: an international comparison Source: Eur Respir J 2001; 18: Suppl. 33, 391s Year: 2001
Late Breaking Abstract - Analysing the COPD care pathway in Japan, Canada, England and Germany: pilot study results Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Lung cancer mortality in Europe and the USA between 2000 and 2017: an observational analysis Source: ERJ Open Res, 7 (4) 00311-2021; 10.1183/23120541.00311-2021 Year: 2021
Healthcare resource consumption in Italian patients with COPD: The MISTRAL study Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
A comparison of patients with newly-diagnosed NSCLC between 3 metropolitan hospitals in Melbourne, Australia between 2012-2014. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
The approach to the surgical management of cancer in four European countries (Belgium, Greece, Switzerland, United Kingdom) Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003
Accuracy of COPD diagnosis in primary care in Knowsley, UK Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017